Thursday, May 25, 2017

Oncogene - Table of Contents alert Volume 36 Issue 21

If you are unable to see the message below, click here to view.


Volume 36, Issue 21 (May 2017)

In this issue
Original Articles
Short Communication

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

Original Articles


Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas OPEN

C Tonelli, M J Morelli, A Sabò, A Verrecchia, L Rotta, T Capra, S Bianchi, S Campaner and B Amati

Oncogene 2017 36: 2921-2929; advance online publication, January 16, 2017; 10.1038/onc.2016.443

Abstract | Full Text

EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis OPEN

S-A Wang, Y-C Wang, Y-P Chuang, Y-H Huang, W-C Su, W-C Chang and J-J Hung

Oncogene 2017 36: 2930-2945; advance online publication, December 19, 2016; 10.1038/onc.2016.445

Abstract | Full Text

A targetable HB-EGF–CITED4 axis controls oncogenesis in lung cancer

C-H Hsieh, Y-T Chou, M-H Kuo, H-P Tsai, J-L Chang and C-W Wu

Oncogene 2017 36: 2946-2956; advance online publication, January 16, 2017; 10.1038/onc.2016.465

Abstract | Full Text

Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma

H Sun, Z Peng, H Tang, D Xie, Z Jia, L Zhong, S Zhao, Z Ma, Y Gao, L Zeng, R Luo and K Xie

Oncogene 2017 36: 2957-2968; advance online publication, February 13, 2017; 10.1038/onc.2016.447

Abstract | Full Text

IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer

Q Yang, X Li, H Chen, Y Cao, Q Xiao, Y He, J Wei and J Zhou

Oncogene 2017 36: 2969-2980; advance online publication, January 16, 2017; 10.1038/onc.2016.448

Abstract | Full Text

Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival

C Kerr, H Szmacinski, M L Fisher, B Nance, J R Lakowicz, A Akbar, J W Keillor, T Lok Wong, R Godoy-Ruiz, E A Toth, D J Weber and R L Eckert

Oncogene 2017 36: 2981-2990; advance online publication, December 12, 2016; 10.1038/onc.2016.452

Abstract | Full Text

TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation

J Li, Y Xi, W Li, R L McCarthy, S A Stratton, W Zou, W Li, S Y Dent, A K Jain and M C Barton

Oncogene 2017 36: 2991-3001; advance online publication, January 9, 2017; 10.1038/onc.2016.453

Abstract | Full Text

The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination OPEN

E Crosas-Molist, E Bertran, I Rodriguez-Hernandez, C Herraiz, G Cantelli, À Fabra, V Sanz-Moreno and I Fabregat

Oncogene 2017 36: 3002-3014; advance online publication, December 12, 2016; 10.1038/onc.2016.454

Abstract | Full Text

PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer

D A Modi, R D Tagare, S Karthikeyan, A Russo, M Dean, D A Davis, D D Lantvit and J E Burdette

Oncogene 2017 36: 3015-3024; advance online publication, December 19, 2016; 10.1038/onc.2016.455

Abstract | Full Text

Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma

H Gurler Main, J Xie, G G Muralidhar, O Elfituri, H Xu, A A Kajdacsy-Balla and M V Barbolina

Oncogene 2017 36: 3025-3036; advance online publication, December 12, 2016; 10.1038/onc.2016.456

Abstract | Full Text

Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic

F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler and N Skuli

Oncogene 2017 36: 3037-3047; advance online publication, December 12, 2016; 10.1038/onc.2016.457

Abstract | Full Text

Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma OPEN

X Wang, M Lang, T Zhao, X Feng, C Zheng, C Huang, J Hao, J Dong, L Luo, X Li, C Lan, W Yu, M Yu, S Yang and H Ren

Oncogene 2017 36: 3048-3058; advance online publication, December 19, 2016; 10.1038/onc.2016.458

Abstract | Full Text

Short Communication


Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma

A Miller, L McLeod, S Alhayyani, A Szczepny, D N Watkins, W Chen, P Enriori, W Ferlin, S Ruwanpura and B J Jenkins

Oncogene 2017 36: 3059-3066; advance online publication, November 28, 2016; 10.1038/onc.2016.437

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: